Literature DB >> 20813010

Recent advances in the understanding of genetic defects of neutrophil number and function.

Gerben Bouma1, Phil J Ancliff, Adrian J Thrasher, Siobhan O Burns.   

Abstract

Neutrophils are amongst the first immune cells to arrive at sites of infection and play an important role as the host's first line of defence against invading pathogens. Defects of neutrophil number or function are usually recognized clinically by recurrent infections that often are life-threatening. Over the last few years, a number of genetic mutations have been discovered to be the basis for congenital neutropenia, adding to our understanding of the molecular basis of these diseases. While many genetic mutations that cause severe congenital neutropenia result in a differentiation block at the promyelocyte stage, defects of neutrophil function are more heterogeneous on clinical, genetic and mechanistic levels. In this review we discuss recent advances in our understanding of the genetic and molecular basis of human neutrophil disorders.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813010     DOI: 10.1111/j.1365-2141.2010.08361.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study.

Authors:  Tadashi Nakasone; Sei Kumakura; Michiko Yamamoto; Tsutomu Murakami; Naoki Yamamoto
Journal:  Med Microbiol Immunol       Date:  2012-07-08       Impact factor: 3.402

3.  Staphylococcus aureus: an introduction.

Authors:  Ian A Myles; Sandip K Datta
Journal:  Semin Immunopathol       Date:  2012-01-27       Impact factor: 9.623

4.  Leukotriene B(4) receptors BLT1 and BLT2 are involved in interleukin-8 production in human neutrophils induced by Trichomonas vaginalis-derived secretory products.

Authors:  Young Hee Nam; Arim Min; Seong Hoon Kim; Young Ah Lee; Kyeong Ah Kim; Kyoung-Ju Song; Myeong Heon Shin
Journal:  Inflamm Res       Date:  2012-01-04       Impact factor: 4.575

Review 5.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

Review 6.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

Review 7.  Immunity against Staphylococcus aureus cutaneous infections.

Authors:  Lloyd S Miller; John S Cho
Journal:  Nat Rev Immunol       Date:  2011-07-01       Impact factor: 53.106

8.  Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination.

Authors:  Selina K Jorch; Bas Gj Surewaard; Mokarram Hossain; Moritz Peiseler; Carsten Deppermann; Jennifer Deng; Ania Bogoslowski; Fardau van der Wal; Abdelwahab Omri; Michael J Hickey; Paul Kubes
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

9.  Immunodeficiency and severe susceptibility to bacterial infection associated with a loss-of-function homozygous mutation of MKL1.

Authors:  Julien Record; Dessislava Malinova; Helen L Zenner; Vincent Plagnol; Karolin Nowak; Farhatullah Syed; Gerben Bouma; James Curtis; Kimberly Gilmour; Catherine Cale; Scott Hackett; Guillaume Charras; Dale Moulding; Sergey Nejentsev; Adrian J Thrasher; Siobhan O Burns
Journal:  Blood       Date:  2015-07-29       Impact factor: 22.113

10.  Neutrophil actin regulation: MKL1 is in control.

Authors:  Marie-Dominique Filippi
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.